Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents.

De-Dong Li,Li Deng,Gan-Hai Hu,Lan-Xue Zhao,Dan-Dan Hu,Yuan-Ying Jiang,Yan Wang
DOI: https://doi.org/10.1248/bpb.b13-00270
2013-01-01
Abstract:Candida albicans is the most common fungal pathogen. Galleria mellonella is widely used as an infection model host. Nevertheless, the G. mellonella-C. albicans infection model had not been optimized for drug evaluation before this study. In this work, we revealed that 5x10(5) colony forming unit (CFU)/larva was a suitable inoculum to optimize the G. mellonella-C. albicans infection model in order to evaluate antifungal agents. Using our optimized model, the antifungal effect of fluconazole, amphotericin B and flucytosine, and the synergy between amphotericin B and flucytosine were successfully verified. Thus, this study provides a rapid, inexpensive and reliable way to evaluate antifungals in vivo.
What problem does this paper attempt to address?